- Home
- atir ie
- Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications, Journal of Biomedical Science
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications, Journal of Biomedical Science
4.5 (595) · $ 6.50 · In stock
Background Gaining further insights into SARS-CoV-2 routes of infection and the underlying pathobiology of COVID-19 will support the design of rational treatments targeting the life cycle of the virus and/or the adverse effects (e.g., multi-organ collapse) that are triggered by COVID-19-mediated adult respiratory distress syndrome (ARDS) and/or other pathologies. Main body COVID-19 is a two-phase disease being marked by (phase 1) increased virus transmission and infection rates due to the wide expression of the main infection-related ACE2, TMPRSS2 and CTSB/L human genes in tissues of the respiratory and gastrointestinal tract, as well as by (phase 2) host- and probably sex- and/or age-specific uncontrolled inflammatory immune responses which drive hyper-cytokinemia, aggressive inflammation and (due to broad organotropism of SARS-CoV-2) collateral tissue damage and systemic failure likely because of imbalanced ACE/ANGII/AT1R and ACE2/ANG(1–7)/MASR axes signaling. Conclusion Here we discuss SARS-CoV-2 life cycle and a number of approaches aiming to suppress viral infection rates or propagation; increase virus antigen presentation in order to activate a robust and durable adaptive immune response from the host, and/or mitigate the ARDS-related “cytokine storm” and collateral tissue damage that triggers the severe life-threatening complications of COVID-19.
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019
Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study
Thymosin-α1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia
Efecto del cotratamiento de COVID-19 con Remdesivir
Kako nastaje kovid infekcija ― uprošćena patofiziologija SARS-CoV-2 virusa, by Nauka u Srbiji, Nauka u Srbiji
Pathogens, Free Full-Text
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
Uprošćena patofiziologija SARS-CoV-2 virusa - Miloš Babić
COVID-19: Coronavirus replication, pathogenesis, and therapeutic
Biomolecules, Free Full-Text
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
Drugs targeting various stages of the SARS-CoV-2 life cycle
